Actuate Therapeutics, Inc. Common stock (ACTU) — Tangible Net Worth Ratio
Actuate Therapeutics, Inc. Common stock (ACTU) has a Tangible Net Worth Ratio of 100.0% as of September 2025. This metric is calculated by deducting intangible assets ($0.00) from net assets ($10.94 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See how liquid is Actuate Therapeutics, Inc. Common stock's working capital to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Actuate Therapeutics, Inc. Common stock Tangible Net Worth Ratio (2022–2024)
This chart shows how Actuate Therapeutics, Inc. Common stock's Tangible Net Worth Ratio has changed across 2 annual periods from 2022 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting net assets of $10.94 Million with intangible assets of $0.00 USD. Also explore net asset momentum of Actuate Therapeutics, Inc. Common stock to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Actuate Therapeutics, Inc. Common stock (2022–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Actuate Therapeutics, Inc. Common stock from 2022 to 2024, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Actuate Therapeutics, Inc. Common stock stock valuation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 100.0% | $104.19K | $0.00 | $9.32 Million | ▲ +0.0 pp |
| 2022 | 100.0% | $14.83 Million | $0.00 | $20.48 Million | — |